CVS is now covering long-acting injectable PrEP, representing a shift from last year when the pharmacy giant announced it was ...

More widespread and consistent use of pre-exposure prophylaxis (PrEP) has the potential to dramatically reduce the incidence of HIV in the U.S., but substantial barriers to PrEP remain, particularly ...

The U.S. Preventive Services Task Force released a recommendation this week calling on health care providers to prescribe all approved PrEP options for people at ...

The trial investigators said that their data supports twice-yearly lenacapavir as superior to oral PrEP options, given the challenges of adhering to a daily regimen. This is not to say that existing ...

She's in bed waiting, and you can't track down where on your body that smell is coming from. Make sure you're clean for her in 5 flat.

The investigational oral pre-exposure prophylaxis (PrEP) agent MK-8527 showed a similar, well-tolerated safety profile to placebo, with dose-proportional pharmacokinetics, among adults with a low ...

The owner of the U.S.' largest pharmacy benefit manager is declining to cover Gilead Sciences’ long-acting HIV prevention breakthrough, at least for now. CVS Health, the parent of PBM juggernaut CVS ...

LAVAL, QC / ACCESSWIRE / March 5, 2024 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) and its gastroenterology business, Salix Pharmaceuticals, today announced findings from its first colonoscopy ...